Effects of Probiotic Ayran on Gingivitis
Effects of the Use of Probiotics Ayran on Gingival Inflammation: An Experimental Gingivitis Study
1 other identifier
interventional
54
1 country
1
Brief Summary
Objectives: This study investigates the effects of daily consumption of probiotic ayran drink on gingival inflammation and the development of experimental gingivitis. Methods: A total of 54volunteer students were included in the present randomized, double-blind, placebo-controlled trial.The participants were divided randomly into two groups; The Control group consisted of 27 participants who consumed placebo ayran, while the 27 participants of the Test group consumed probiotic ayran (containing Lactobacillus acidophilus and Bifidobacterium bifidum) for 42 days twice a day.After 42 days, mechanical plaque control was interrupted for 5 days. The clinical parameters of gingivitis; Plaque index (PI), gingival index (GI), probing bleeding (BOP), probing depth (PPD) were recorded at baseline, day 42 (beginning of experimental gingivitis) and day 47 (the end of experimental gingivitis). At the same time points, gingival crevicular fluid had been collected for analysis of matrix metalloproteinase - 8 (MMP-8).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2023
CompletedFirst Submitted
Initial submission to the registry
May 22, 2024
CompletedFirst Posted
Study publicly available on registry
May 31, 2024
CompletedMay 31, 2024
May 1, 2024
3 months
May 22, 2024
May 29, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Plaque index
PI was scored from 0 to 5 according to the color change obtained with the Mira-2 solution
Plaque index will be recorded at baseline, at day 42 and 47
Gingival index
GI is graded by visual assessment and mechanical stimulation of the gingival tissues, scoring the gingival condition according to the criteria
Gingival index will be recorded at baseline, at day 42 and 47
Bleeding on probing
The probing bleeding (BOP) index was determined by the presence/absence of bleeding ≈30 seconds after probing
BOP will be recorded at baseline, at day 42 and 47
Study Arms (2)
Probiotic ayran drink
EXPERIMENTALThe participants in this experimental group will use probiotic containing ayran for 42 days and then will be subjected to 5 days of experimental gingivitis.
Placebo ayran drink
PLACEBO COMPARATORThe participants in this control group will use control ayran without probiotics for 42 days and then will be subjected to 5 days of experimental gingivitis.
Interventions
The test group has received probiotic ayran drink for 6 weeks
The control group has received placebo ayran drink for 6 weeks
Eligibility Criteria
You may qualify if:
- Systemic healthy
- Subjects with gingivitis defined as a BOP sites ≥ 10% and PD ≤ 3 mm
- No radiographic bone loss
- Non-smoking participants
You may not qualify if:
- History of using antibiotics or anti-inflammatory drugs or probiotic preparations or food supplements in the last 6 months,
- Undergoing orthodontic treatment,
- Active carious lesions
- Mouth breathing
- History of allergy for milk or fermented milk products.
- Taking medications affecting the gingiva and/or oral mucosa
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cukurova University Faculty of Dentistry
Adana, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cenk Haytac, phd
Professor Doctor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 22, 2024
First Posted
May 31, 2024
Study Start
January 15, 2023
Primary Completion
April 15, 2023
Study Completion
June 15, 2023
Last Updated
May 31, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The data is ready and can be shared for two years
- Access Criteria
- The data will be shared upon request
The data will be shared upon request